Vijaya Diagnostic Centre Share Price Today (VIJAYA)
TODAY IN ONE LINE
VIJAYA rose 2.8% on light volume, outperforming Nifty's 1.0% move, supported by recent strong earnings.
With a market cap of ₹13,886.97 Cr., it trades at a P/E of 80.19. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Vijaya Diagnostic Centre flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 38.0% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 26.6% and Profit up 34.6%
- ●High Capital EfficiencyROCE of 21.3% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 19.7%
- ●Healthy Operating MarginsOPM is structurally strong at 41.4%
- ●High Promoter HoldingPromoters hold 52.5% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 81.4x
- ●FII SellingFII holding decreased by 1.73% QoQ
Latest Vijaya Diagnostic Centre News
What changed recently?
Recent events, corporate actions, and announcements.
Vijaya Diagnostic Centre Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Vijaya Diagnostic Centre Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Vijaya Diagnostic Centre Ltd trades at a P/E of 80.19× and P/B of 14.49×, against the Healthcare sector median P/E of 44.57×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Vijaya Diagnostic Centre Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Vijaya Diagnostic Centre Ltd — derived from the live tape, not yesterday's close.
Vijaya Diagnostic Centre Ltd last traded at ₹1,350.8 with an intraday range of ₹1,308.2–₹1,357.8 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹1350.80| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1468.87 | +118.07 | +8.74% |
| R3 | 1419.27 | +68.47 | +5.07% |
| R2 | 1388.53 | +37.73 | +2.79% |
| R1 | 1369.67 | +18.87 | +1.40% |
| PIVOT | 1338.93 | -11.87 | -0.88% |
| CURRENT | 1350.80 | — | — |
| S1 | 1320.07 | -30.73 | -2.28% |
| S2 | 1289.33 | -61.47 | -4.55% |
| S3 | 1270.47 | -80.33 | -5.95% |
| S4 | 1220.87 | -129.93 | -9.62% |
VIJAYA is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹1308.2–₹1339.5
Trading Above opening range, showing Bullishness
Vijaya Diagnostic Centre Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Vijaya Diagnostic Centre Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Vijaya Diagnostic Centre Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹13,886.97 Cr. and reported EPS of ₹16.80.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 681 | 814 ▲ 19.5% |
| Sales Growth YoY %Derived | 24.39% | 19.49% |
| Other Income | 18 | 21 ▲ 13.5% |
| Total Income | 700 | 835 ▲ 19.3% |
| 85 | 95 ▲ 11.7% | |
| Gross ProfitDerived | 597 | 720 ▲ 20.6% |
| Gross Margin %Derived | 87.56% | 88.37% |
| 323 | 383 ▲ 18.3% | |
| EBITDA (Operating Profit)Derived | 273 | 337 ▲ 23.3% |
| OPM %Derived | 40.10% | 41.38% |
| 96 | 125 ▲ 29.8% | |
| Profit Before Tax (PBT) | 193 | 233 ▲ 20.5% |
| 49 | 60 ▲ 20.9% | |
| Effective Tax %Derived | 25.56% | 25.66% |
| Total Profit for Period | 144 | 173 ▲ 20.3% |
| Less: Non-controlling Interests | 1 | — ▼ 100.0% |
| Net Profit (Owner's PAT)Derived | 143 | 173 ▲ 20.9% |
| Net Profit Margin %Derived | 21.00% | 21.24% |
| PAT Growth YoY %Derived | 20.41% | 20.90% |
| Earnings Per Share (EPS ₹) | 13.94 | 16.81 ▲ 20.6% |
| Diluted Shares Outstanding (Cr) | 10 | 10 ▲ 0.3% |
| Other Comprehensive Income (Net of Tax) | 0 | 1 ▲ 16571.8% |
| Total Expenses (incl. D&A & Interest) | 507 | 602 ▲ 18.9% |
| Material Cost % of RevenueDerived | 12.44% | 11.63% |
| Employee Cost % of RevenueDerived | 16.46% | 16.06% |
| Other Cost % of RevenueDerived | 31.00% | 30.93% |
| Interest Coverage (x)Derived | 7.58x | 7.38x |
| Period | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|
| Revenue from Operations | 462 | 459 ▼ 0.7% | 548 ▲ 19.3% | 681 ▲ 24.4% | 814 ▲ 19.5% | |
| Sales Growth YoY %Derived | — | -0.68% | 19.29% | 24.39% | 19.49% | |
| Other Income | 13 | 14 ▲ 10.3% | 21 ▲ 47.1% | 18 ▼ 12.0% | 21 ▲ 13.5% | |
| Total Income | 475 | 473 ▼ 0.4% | 569 ▲ 20.1% | 700 ▲ 23.1% | 835 ▲ 19.3% | |
71 | 59 ▼ 17.6% | 65 ▲ 11.1% | 85 ▲ 29.5% | 95 ▲ 11.7% | ||
| Gross ProfitDerived | 391 | 400 ▲ 2.4% | 482 ▲ 20.5% | 597 ▲ 23.7% | 720 ▲ 20.6% | |
| Gross Margin %Derived | 84.54% | 87.18% | 88.05% | 87.56% | 88.37% | |
187 | 218 ▲ 16.6% | 261 ▲ 19.8% | 323 ▲ 23.7% | 383 ▲ 18.3% | ||
| EBITDA (Operating Profit)Derived | 204 | 182 ▼ 10.6% | 221 ▲ 21.4% | 273 ▲ 23.7% | 337 ▲ 23.3% | |
| OPM %Derived | 44.05% | 39.64% | 40.32% | 40.10% | 41.38% | |
69 | 83 ▲ 19.6% | 79 ▼ 4.5% | 96 ▲ 22.0% | 125 ▲ 29.8% | ||
| Profit Before Tax (PBT) | 147 | 114 ▼ 23.0% | 159 ▲ 39.8% | 193 ▲ 21.7% | 233 ▲ 20.5% | |
37 | 28 ▼ 22.9% | 39 ▲ 37.9% | 49 ▲ 26.4% | 60 ▲ 20.9% | ||
| Effective Tax %Derived | 24.91% | 24.93% | 24.61% | 25.56% | 25.66% | |
| Total Profit for Period | 111 | 85 ▼ 23.0% | 120 ▲ 40.4% | 144 ▲ 20.2% | 173 ▲ 20.3% | |
| Less: Non-controlling Interests | 1 | 1 ▼ 41.7% | 1 ▲ 41.1% | 1 ▼ 11.5% | — ▼ 100.0% | |
| Net Profit (Owner's PAT)Derived | 110 | 85 ▼ 22.8% | 119 ▲ 40.4% | 143 ▲ 20.4% | 173 ▲ 20.9% | |
| Net Profit Margin %Derived | 23.72% | 18.43% | 21.69% | 21.00% | 21.24% | |
| PAT Growth YoY %Derived | — | -22.84% | 40.40% | 20.41% | 20.90% | |
| Earnings Per Share (EPS ₹) | 10.76 | 8.29 ▼ 23.0% | 11.61 ▲ 40.0% | 13.94 ▲ 20.1% | 16.81 ▲ 20.6% | |
| Diluted Shares Outstanding (Cr) | 10 | 10 ▲ 0.1% | 10 ▲ 0.3% | 10 ▲ 0.3% | 10 ▲ 0.3% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▼ 2.4% | -0 ▼ 155.7% | 0 ▲ 103.5% | 1 ▲ 16571.8% | |
| Total Expenses (incl. D&A & Interest) | 328 | 360 ▲ 9.8% | 410 ▲ 13.9% | 507 ▲ 23.6% | 602 ▲ 18.9% | |
| Material Cost % of RevenueDerived | 15.46% | 12.82% | 11.95% | 12.44% | 11.63% | |
| Employee Cost % of RevenueDerived | 15.28% | 17.09% | 16.47% | 16.46% | 16.06% | |
| Other Cost % of RevenueDerived | 25.20% | 30.45% | 31.26% | 31.00% | 30.93% | |
| Interest Coverage (x)Derived | 9.18x | 5.74x | 6.83x | 7.58x | 7.38x |
Vijaya Diagnostic Centre segment analysis : revenue and profit mix.
Disclosed business segments at Vijaya Diagnostic Centre with their share of revenue and profit, switchable between consolidated and standalone reporting.
Vijaya Diagnostic Centre discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Vijaya Diagnostic Centre Ltd.
Our AI distills the core fundamental drivers supporting Vijaya Diagnostic Centre Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Vijaya Diagnostic Centre Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating margin 30.10% substantially exceeds peer median 16.35%, demonstrating superior pricing power.
Latest quarterly EPS grew 38.4% YoY, indicating robust earnings momentum and profitability.
TTM revenue grew 26.6% YoY, significantly outpacing peer median quarterly growth of 3.5%.
ROE 19.70% and ROCE 21.30% reflect efficient capital deployment and superior returns.
Promoter holding 52.5% signals strong management alignment and long-term commitment.
Key Risks.
P/E ratio 81.38x far exceeds peer median 53.47x, suggesting significant valuation premium.
Dividend yield 0.15% offers minimal income return for equity investors seeking regular yields.
Total debt ₹423 Cr with debt-to-equity 0.0044 elevated for healthcare services sector.
Price near 52-week high ₹1,440.00 limits near-term upside potential for new investors.
Free cash flow ₹45.30 Cr (latest quarter) declining trend signals cash generation pressure.
Flip Conditions.
Valuation risk. a P/E above 104 (~2.3× the sector multiple of 44.6) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 15% would indicate weaker capital compounding.
Vijaya Diagnostic Centre Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Vijaya Diagnostic Centre Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Vijaya Diagnostic Centre Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Vijaya Diagnostic Centre Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Vijaya Diagnostic Centre Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Vijaya Diagnostic Centre Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Vijaya Diagnostic Centre Ltd stood at 41.2% of traded volume, against a 20-day average of 43.4%.
Vijaya Diagnostic Centre announcements: results, concalls, ratings, M&A.
Filings Vijaya Diagnostic Centre sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Vijaya Diagnostic Centre files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 134 documents below.
Allotment of Securities
Vijaya Diagnostic Centre Limited has informed the Exchange regarding allotment of 100987 securities pursuant to ESOP/ESPS at its meeting held on July…
Copy of Newspaper Publication
Vijaya Diagnostic Centre Limited has informed the Exchange about Copy of Newspaper Publication
Shareholders meeting
Vijaya Diagnostic Centre Limited has informed the Exchange regarding Notice of Postal Ballot
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Vijaya Diagnostic Centre Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Options to purchase securities
Vijaya Diagnostic Centre Limited has informed the Exchange about Options to purchase securities
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Vijaya Diagnostic Centre dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Vijaya Diagnostic Centre has declared, sequenced by announce and record date.
Vijaya Diagnostic Centre corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Vijaya Diagnostic Centre Ltd: business, sector, key facts.
What Vijaya Diagnostic Centre Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Vijaya Diagnostic Centre Ltd operates in the Healthcare Service Provider industry under the Healthcare sector, listed as NSE: VIJAYA, BSE: 543350.
Vijaya Diagnostic Centre Limited is a prominent provider of diagnostic healthcare services in India, primarily operating within the country. Their extensive service offerings cater to a wide range of patient needs, encompassing a comprehensive suite of diagnostic tests and imaging procedures.
The core of Vijaya's business lies in its laboratory services. This includes a broad spectrum of clinical pathology tests, microbiology analyses, hematology assessments, serology studies, histopathology examinations, and cytogenetic investigations. Furthermore, they offer advanced biochemical testing and molecular diagnostics, providing a deep and detailed analysis of patient samples.
Beyond laboratory work, Vijaya Diagnostic Centre offers a complete range of sophisticated medical imaging services. This includes Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) scans, including advanced 3T MRI technology, ultrasound imaging, and X-ray procedures. They also provide specialized imaging services in cardiology, gastroenterology, and nuclear medicine, including Positron Emission Tomography/Computed Tomography (PET/CT) scans.
Complementing its diagnostic services, Vijaya also provides convenient health checkup packages designed for preventative care and early disease detection. The company further enhances accessibility through its home sample collection service, bringing convenience and ease to patients needing diagnostic tests.
Established in 1981 and headquartered in Hyderabad, India, Vijaya Diagnostic Centre Limited has a long history of providing high-quality diagnostic services. Their comprehensive range of offerings, from basic laboratory tests to advanced imaging, positions them as a significant player in the Indian healthcare landscape.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Health X Platform (HEALTHX) Share PricePeer
- Krsnaa Diagnostics (KRSNAA) Share PricePeer
- Dr Lal Path Labs (LALPATHLAB) Share PricePeer
- Metropolis Healthcare (METROPOLIS) Share PricePeer
- Suraksha Diagnostic (SURAKSHA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top quality scorecard stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Vijaya Diagnostic Centre Ltd (VIJAYA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Vijaya Diagnostic Centre Ltd (VIJAYA)?
The current share price of Vijaya Diagnostic Centre Ltd (VIJAYA) is ₹1,350.8. Today, the stock has gained by ₹36.90 (2.81%), trading in a range of ₹1,308.2 to ₹1,357.8. The stock opened at ₹1,322 with a trading volume of 84,864 shares.
02Is Vijaya Diagnostic Centre Ltd stock a good investment for long-term?
Vijaya Diagnostic Centre Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹13,886.97 crores, P/E ratio of 80.19, ROE of 19.70%, and ROCE of 21.30%. The dividend yield stands at 0.15%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Vijaya Diagnostic Centre Ltd stock?
The 52-week high price of Vijaya Diagnostic Centre Ltd (VIJAYA) is ₹1,440, while the 52-week low is ₹848. Currently trading at ₹1,350.8, the stock is 84.9% away from its 52-week low and 6.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Vijaya Diagnostic Centre Ltd stock at the current price?
Whether to buy Vijaya Diagnostic Centre Ltd stock at ₹1,350.8 depends on multiple factors. The stock is currently trading with a P/E ratio of 80.19 and P/B ratio of 14.49. Today's performance shows a gain of 2.81%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Vijaya Diagnostic Centre Ltd and when is the next dividend?
Vijaya Diagnostic Centre Ltd offers a dividend yield of 0.15%, which means for every ₹100 invested at the current price of ₹1,350.8, you can expect to receive approximately ₹0.15 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Vijaya Diagnostic Centre Ltd?
Vijaya Diagnostic Centre Ltd's key financial metrics include: P/E Ratio: 80.19, P/B Ratio: 14.49, ROE: 19.70%, ROCE: 21.30%, Dividend Yield: 0.15%, EPS: ₹16.80, Book Value: ₹93, and Debt-to-Equity: 0.44. The company's market cap stands at ₹13,886.97 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Vijaya Diagnostic Centre Ltd stock performing today in the market?
Vijaya Diagnostic Centre Ltd stock opened at ₹1,322 and is currently trading at ₹1,350.8, showing a gain of ₹36.90 (2.81%). The intraday high is ₹1,357.8 and low is ₹1,308.2. The trading volume stands at 84,864 shares, indicating moderate market participation today.
08What is the P/E ratio of Vijaya Diagnostic Centre Ltd and what does it indicate?
Vijaya Diagnostic Centre Ltd has a Price-to-Earnings (P/E) ratio of 80.19, which means investors are willing to pay ₹80.19 for every ₹1 of earnings. With an EPS of ₹16.80, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Vijaya Diagnostic Centre Ltd (VIJAYA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.